IS7320A - Peptíð ætluð til meðhöndlunar á krabbameini tengdu þekjuæxlisveiru (HPV) í manni og öðrum þekjuvefsæxlum - Google Patents

Peptíð ætluð til meðhöndlunar á krabbameini tengdu þekjuæxlisveiru (HPV) í manni og öðrum þekjuvefsæxlum

Info

Publication number
IS7320A
IS7320A IS7320A IS7320A IS7320A IS 7320 A IS7320 A IS 7320A IS 7320 A IS7320 A IS 7320A IS 7320 A IS7320 A IS 7320A IS 7320 A IS7320 A IS 7320A
Authority
IS
Iceland
Prior art keywords
epithelial
hpv
cancer
treatment
human carcinoma
Prior art date
Application number
IS7320A
Other languages
English (en)
Other versions
IS2906B (is
Inventor
Gonzalez Barrios Belkis
Puchades Izaguirre Yaquelin
Santos Savio Alicia
Silva Rodriguez Ricardo
Javier Gonzalez Lopez Luis
Moro Soria Alejandro
Ernesto Perea Rodriguez Silvio
Reyes Acosta Osvaldo
Francisco Santiago Vispo Nelson
Original Assignee
Centro De Ingenieria Genetica Y Biotechnologia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro De Ingenieria Genetica Y Biotechnologia filed Critical Centro De Ingenieria Genetica Y Biotechnologia
Publication of IS7320A publication Critical patent/IS7320A/is
Publication of IS2906B publication Critical patent/IS2906B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IS7320A 2001-12-20 2004-06-16 Peptíð til meðhöndlunar á krabbameini sem tengist vörtuveiru manna (HPV) og önnur þekjuæxli IS2906B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20010309A CU23225A1 (es) 2001-12-20 2001-12-20 PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES
PCT/CU2002/000010 WO2003054002A1 (es) 2001-12-20 2002-12-04 Péptidos para el tratamiento del cáncer asociado al virus papiloma humano (vph) y de otros tumores epiteliales

Publications (2)

Publication Number Publication Date
IS7320A true IS7320A (is) 2004-06-16
IS2906B IS2906B (is) 2014-11-15

Family

ID=40091679

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7320A IS2906B (is) 2001-12-20 2004-06-16 Peptíð til meðhöndlunar á krabbameini sem tengist vörtuveiru manna (HPV) og önnur þekjuæxli

Country Status (33)

Country Link
US (2) US7374767B2 (is)
EP (2) EP2383282A1 (is)
JP (1) JP4056476B2 (is)
KR (1) KR100642437B1 (is)
CN (1) CN100368431C (is)
AR (1) AR037825A1 (is)
AT (1) ATE520704T1 (is)
AU (1) AU2002361922B2 (is)
BR (1) BRPI0215213C1 (is)
CA (1) CA2471110C (is)
CR (1) CR7361A (is)
CU (1) CU23225A1 (is)
DK (1) DK1491553T3 (is)
DO (1) DOP2002000548A (is)
ES (1) ES2371239T3 (is)
HN (1) HN2002000377A (is)
HR (1) HRP20040663B1 (is)
IL (2) IL162633A0 (is)
IS (1) IS2906B (is)
MA (1) MA27868A1 (is)
MX (1) MXPA04005832A (is)
MY (1) MY133530A (is)
NO (1) NO333259B1 (is)
NZ (1) NZ534170A (is)
PE (1) PE20030861A1 (is)
PT (1) PT1491553E (is)
RU (1) RU2290410C2 (is)
SI (1) SI1491553T1 (is)
TN (1) TNSN04114A1 (is)
UA (1) UA81403C2 (is)
UY (1) UY27602A1 (is)
WO (1) WO2003054002A1 (is)
ZA (1) ZA200405514B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23225A1 (es) * 2001-12-20 2007-08-30 Ct Ingenieria Genetica Biotech PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES
CU23431B6 (es) * 2005-05-12 2009-10-16 Ct Ingenieria Genetica Biotech Método para la inhibición de la proliferación de células tumorales y el tratamiento del cáncer
GB2433740A (en) * 2005-12-23 2007-07-04 Rapid Biosensor Systems Ltd Detection of tuberculosis infection
CU23511B6 (es) * 2006-02-28 2010-04-13 Biorec B V Combinación farmacéutica para el tratamiento y/o quimiosensibilización de tumores refractarios a drogas anticancerígenas
GB2441131A (en) * 2006-08-24 2008-02-27 Univ Dundee Modulation of binding of CK2a to NDPK
CN100522992C (zh) * 2007-02-12 2009-08-05 中国科学院昆明动物研究所 一种环状小肽ba
EP2133083A4 (en) * 2007-03-27 2012-02-15 Taiko Pharmaceutical Co Ltd THERAPEUTIC FOR SKIN OR MOLECULE INFECTIONS
US20110305706A1 (en) 2009-02-23 2011-12-15 Scott Thomas Brady Compositions and Methods for Treating a Disease Mediated by Soluble Oligomeric Amyloid Beta
CA2755245A1 (en) * 2009-03-13 2010-09-16 Egen, Inc. Compositions and methods for the delivery of biologically active rnas
IL290457B2 (en) 2015-12-30 2025-02-01 Kodiak Sciences Inc Antibodies and their conjugates
CU20200103A7 (es) * 2020-12-18 2022-07-08 Ct Ingenieria Genetica Biotecnologia Péptido sintético para la inducción de inmunidad antitumoral y antiviral
CU24766B1 (es) 2021-07-09 2025-08-13 Ct Ingenieria Genetica Biotecnologia Péptidos lineales que inhiben la fosforilación mediada por ck2
CN118370805B (zh) * 2024-04-29 2025-02-14 广州中科佰氏健康产业有限公司 一种抑菌妇科凝胶及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE902820A1 (en) 1989-08-07 1991-02-27 Merck & Co Inc Peptide inhibitors of human papilloma virus protein binding¹to retinoblastoma gene proteins
JPH05310784A (ja) * 1991-09-04 1993-11-22 Merck & Co Inc ヒト乳頭腫ウイルスタンパク質と網膜芽細胞腫遺伝子タンパク質との結合のペプチド阻害剤
GB9313556D0 (en) 1993-07-01 1993-08-18 British Tech Group Synthetic peptides of human papillomavirus
US5625031A (en) * 1994-02-08 1997-04-29 Bristol-Myers Squibb Company Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoprotein
ATE235509T1 (de) * 1998-06-30 2003-04-15 Deutsches Krebsforsch Peptide zur inhibition von hpv e7 proteinen
US6641994B2 (en) * 1999-08-25 2003-11-04 Pharmacia & Upjohn Company Methods of identifying anti-viral agents
AU2001238347A1 (en) * 2000-02-28 2001-09-12 Hyseq, Inc. Novel nucleic acids and polypeptides
CU23225A1 (es) * 2001-12-20 2007-08-30 Ct Ingenieria Genetica Biotech PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES

Also Published As

Publication number Publication date
IL162633A (en) 2011-02-28
AU2002361922B2 (en) 2007-04-05
CR7361A (es) 2005-02-18
UA81403C2 (en) 2008-01-10
SI1491553T1 (sl) 2011-12-30
ZA200405514B (en) 2005-03-30
HRP20040663A2 (en) 2005-08-31
JP2005525090A (ja) 2005-08-25
RU2004122084A (ru) 2005-03-27
CA2471110A1 (en) 2003-07-03
UY27602A1 (es) 2003-04-30
NZ534170A (en) 2006-08-31
CN1620464A (zh) 2005-05-25
DOP2002000548A (es) 2003-06-30
EP2383282A1 (en) 2011-11-02
MXPA04005832A (es) 2004-09-13
TNSN04114A1 (en) 2006-06-01
HN2002000377A (es) 2003-04-10
KR100642437B1 (ko) 2006-11-06
IS2906B (is) 2014-11-15
CA2471110C (en) 2017-01-31
US20060233742A1 (en) 2006-10-19
IL162633A0 (is) 2005-11-20
WO2003054002A1 (es) 2003-07-03
JP4056476B2 (ja) 2008-03-05
HK1068901A1 (en) 2005-05-06
AU2002361922A1 (en) 2003-07-09
BRPI0215213B1 (pt) 2018-09-11
MY133530A (en) 2007-11-30
US7374767B2 (en) 2008-05-20
MA27868A1 (fr) 2006-05-02
AR037825A1 (es) 2004-12-09
PT1491553E (pt) 2011-11-25
US20090005294A1 (en) 2009-01-01
NO20043112L (no) 2004-07-20
KR20050002811A (ko) 2005-01-10
BR0215213A (pt) 2004-12-07
EP1491553A1 (en) 2004-12-29
ES2371239T3 (es) 2011-12-28
DK1491553T3 (da) 2011-12-05
HRP20040663B1 (hr) 2013-05-31
ATE520704T1 (de) 2011-09-15
PE20030861A1 (es) 2003-12-02
CU23225A1 (es) 2007-08-30
NO333259B1 (no) 2013-04-22
EP1491553B1 (en) 2011-08-17
US7947287B2 (en) 2011-05-24
CN100368431C (zh) 2008-02-13
BRPI0215213C1 (pt) 2021-05-25
RU2290410C2 (ru) 2006-12-27

Similar Documents

Publication Publication Date Title
IS6965A (is) Ganglíósíð-tengd raðbrigða mótefni og notkun þeirra í sjúkdómsgreiningu og meðferð á æxlum
IS2468B (is) Aðferðir og milliefni til framleiðslu á efnasamböndum gegn krabbameini
IL202332A0 (en) Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
IS7137A (is) Samsett meðferð til meðhöndlunar á krabbameini
NO20052760D0 (no) Fremgangsmate for behandling av kreft og beslektede fremgangsmater.
IS6303A (is) Notkun retígabíns til meðhöndlunar á taugasjúkdómatengdum sársauka
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
MY136095A (en) Use of human anti-ctla-4 antibodies for treatment of cancer
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
NO20015516L (no) Preparater og anvendelser av ET743 for behandling av kreft
IS6375A (is) Lyfjagjöf til öftrunar á blöðruhálskrabbameini
DK1567641T3 (da) Proaerolysin indeholdende proteaseaktiveringssekvenser og fremgangsmåder til anvendelse til behandling af prostatacancer.
AU2003219555A8 (en) Depsipeptide for therapy of kidney cancer
IS2906B (is) Peptíð til meðhöndlunar á krabbameini sem tengist vörtuveiru manna (HPV) og önnur þekjuæxli
AU2003254641A8 (en) Interferon beta-like molecules for treatment of cancer
WO2003026494A3 (en) Galectins-1-and-4 in tumor development
IS3004B (is) Aðferð til meðhöndlunar á svefnleysi á frumstigi
IS6707A (is) Efnablanda til forvarna og meðhöndlunar á krabbameini
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
IS7024A (is) 4-(fenýl-píperidín-4-ýlíden-metýl)-bensamíðafleiður og notkun þeirra til meðhöndlunar á sársauka, kvíða eða truflunum í maga og þörmum
AU2002346049A1 (en) Coactivators in the diagnosis and treatment of breast cancer
DK1372665T3 (da) Hormonerstatningsbehandling og administration
AU2003258134A8 (en) Lung cancer target proteins and use thereof
AU2002366195A8 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer